An Oklahoma court case highlights the health care giant’s role in the epidemic as a leading supplier of opioid ingredients. Source: NYT > Business – Katie Thomas and Tiffany Hsu
$572 Million Decision Against Johnson & Johnson in Landmark Opioid Trial
The first case against a drug manufacturer for the national public health disaster may indicate what lies ahead in 2,000 more lawsuits. Source: NYT > Business – Jan Hoffman
McKinsey Advised Johnson & Johnson on Increasing Opioid Sales
In a trial in Oklahoma, records showed the firm was consulted about sales at a time when abuse of pain medicine was widespread. Cases in two other states also shed light on its role. Source: NYT > Business – Walt Bogdanich
Back-to-School Sales Tax ‘Holidays’ Lure Shoppers Despite Slim Savings
“People who won’t walk across the street to save $5 on a pair of pants will take a day off from work to take advantage of a sales-tax holiday,” a tax expert said. Source: NYT > Business – Ann Carrns
Oklahoma Faces Off Against J & J in First Trial of an Opioid Maker
With Purdue Pharma and Teva settling the case, the state sought to hold J & J responsible for the broader opioid crisis. The company argued that it operated responsibly and lawfully. Source: NYT > Business – Jan Hoffman
Purdue Pharma Will Settle Major Opioid Lawsuit
The Oklahoma attorney general will announce details Tuesday afternoon. A trial of other opioid manufacturers is still scheduled to proceed. Source: NYT > Business – JAN HOFFMAN